WGRX

Wellgistics Health, Inc.

Price Chart

Latest Quote

$2.72

-0.02 (-0.91%)

Current Price

Previous Close	$2.75
Open	$2.61
Day High	$2.81
Day Low	$2.61
Volume	10,136

Fetched: 2026-07-17T16:56:32

Stock Information

Shares Outstanding	2.51M
Total Debt	$28.73M
Cash Equivalents	$52K
Revenue	$14.03M
Net Income	$-76.59M
Sector	Healthcare
Industry	Pharmaceutical Retailers
Market Cap	$6.84M
EPS (TTM)	$-44.00
Exchange	NCM

🌐 Visit Website

Recent Price History

Date	Close	Volume
2026-07-17	$2.65	13,600
2026-07-16	$2.66	35,200
2026-07-15	$2.84	14,500
2026-07-14	$2.93	26,600
2026-07-13	$2.91	18,200
2026-07-10	$3.07	13,400
2026-07-09	$2.95	7,100
2026-07-08	$2.88	10,500
2026-07-07	$2.98	18,100
2026-07-06	$3.13	26,200
2026-07-02	$2.98	9,400
2026-07-01	$3.07	11,100
2026-06-30	$3.10	60,200
2026-06-29	$2.93	12,900
2026-06-26	$3.05	20,900
2026-06-25	$2.86	24,800
2026-06-24	$2.82	29,500
2026-06-23	$3.12	21,200
2026-06-22	$3.10	40,200
2026-06-18	$3.39	34,000

About Wellgistics Health, Inc.

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

📰 Latest News

Wellgistics Health, Datavault AI Agree to Form DelivMeds AI

MT Newswires • 2026-05-20T14:27:01Z

Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform

Insider Monkey • 2026-04-03T00:08:27Z

BC-Most Active Stocks

Associated Press Finance • 2026-03-12T14:30:35Z

Datavault AI (DVLT), Wellgistics Health Expand Partnership to Launch Blockchain-Powered HaaS Model

Insider Monkey • 2026-02-25T10:45:14Z

Wellgistics Health provides corporate outlook for 2026

TipRanks • 2026-01-08T12:46:56Z

Could Blockchain Integration Signal a New Competitive Edge for Wellgistics Health (WGRX)?

Simply Wall St. • 2025-10-26T23:10:02Z

XRP Ledger Used by Nasdaq-Listed Pharma Distributor to Power Payment System for Pharmacies

CoinDesk • 2025-08-16T11:00:44Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$29,764,279	$16,361,517	$0	$27,028,874
Cost Of Revenue	$29,764,279	$16,361,517	$0	$27,028,874
Total Revenue	$23,337,860	$18,128,831	$0	$32,777,728
Operating Revenue	$23,337,860	$18,128,831	$0	$32,777,728
Expenses
Interest Expense	$4,579,556	$831,467	$15,081	$287,183
Total Expenses	$104,532,691	$24,273,963	$2,880,603	$36,200,457
Other Income Expense	$-15,500,143	$120,373	$98,132	$966,112
Other Non Operating Income Expenses	$42,045	$120,373	$180,461	$-851,942
Net Non Operating Interest Income Expense	$-4,579,556	$-831,467	$-15,081	$-287,183
Interest Expense Non Operating	$4,579,556	$831,467	$15,081	$287,183
Operating Expense	$74,768,412	$7,912,446	$2,880,603	$9,171,583
Selling And Marketing Expense	$1,224,521	$0	-	-
General And Administrative Expense	$70,332,827	$6,797,782	$2,880,603	$7,082,600
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Net Interest Income	$-4,579,556	$-831,467	$-15,081	$-287,183
Normalized Income	$-85,732,342	$-6,856,226	$-2,895,684	$-4,561,854
Net Income From Continuing And Discontinued Operation	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Total Operating Income As Reported	$-93,749,097	$-6,145,132	$-2,880,603	$-3,422,729
Net Income Common Stockholders	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Net Income	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Net Income Including Noncontrolling Interests	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Net Income Continuous Operations	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Pretax Income	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Special Income Charges	$-15,542,188	$0	-	$1,818,054
Operating Income	$-81,194,831	$-6,145,132	$-2,880,603	$-3,422,729
Depreciation Amortization Depletion Income Statement	$3,211,064	$1,114,664	$0	$2,087,583
Depreciation And Amortization In Income Statement	$3,211,064	$1,114,664	$0	$2,087,583
Gross Profit	$-6,426,419	$1,767,314	$0	$5,748,854
Earnings From Equity Interest	-	-	$-82,329	-
Per Share
Diluted EPS	$-71.50	$-7.50	$-3.00	$-2.90
Basic EPS	$-71.50	$-7.50	$-3.00	$-2.90
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-77,941,722	$-4,910,095	$-2,880,603	$-2,187,088
Total Unusual Items	$-15,542,188	$0	-	$1,818,054
Total Unusual Items Excluding Goodwill	$-15,542,188	$0	-	$1,818,054
Reconciled Depreciation	$3,211,064	$1,114,664	$0	$2,087,583
EBITDA (Bullshit earnings)	$-93,483,910	$-4,910,095	$-2,880,603	$-369,034
EBIT	$-96,694,974	$-6,024,759	$-2,880,603	$-2,456,617
Diluted Average Shares	$1,419,724	$945,041	$894,400	$945,041
Basic Average Shares	$1,419,724	$945,041	$894,400	$945,041
Diluted NI Availto Com Stockholders	$-101,274,530	$-6,856,226	$-2,895,684	$-2,743,800
Tax Provision	$0	$0	$0	$0
Other Special Charges	$2,987,922	-	-	$-1,818,054
Impairment Of Capital Assets	$12,554,266	$0	-	-
Selling General And Administration	$71,557,348	$6,797,782	$2,880,603	$7,082,600
Other Gand A	$70,332,827	$6,797,782	$2,880,603	$7,082,600
Research And Development	-	-	$375	$1,400

Fetched: 2026-07-06

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$-38,806,757	$-31,849,509	$-2,900,434	$-5,250
Total Assets	$30,459,449	$57,332,650	$338,364	$0
Total Non Current Assets	$27,640,233	$42,163,982	$0	$0
Non Current Prepaid Assets	$85,008	$85,008	$0	-
Non Current Note Receivables	$0	$139,771	$0	-
Goodwill And Other Intangible Assets	$26,358,956	$38,583,955	$0	-
Other Intangible Assets	$12,165,033	$22,364,026	-	-
Current Assets	$2,819,216	$15,168,668	$338,364	$0
Current Deferred Assets	$0	$875,385	$0	-
Prepaid Assets	$0	$524	$0	-
Inventory	$1,639,426	$9,518,608	$0	-
Receivables	$1,137,219	$3,745,814	$337,000	$0
Accounts Receivable	$1,137,219	$2,724,814	$0	-
Allowance For Doubtful Accounts Receivable	$-847,205	$-940,596	$0	-
Gross Accounts Receivable	$1,984,424	$3,665,410	$0	-
Cash Cash Equivalents And Short Term Investments	$42,571	$1,028,336	$1,364	$0
Cash And Cash Equivalents	$42,571	$1,028,336	$1,364	$0
Other Non Current Assets	-	$1,438,940	-	-
Other Current Assets	-	$1	-	-
Debt
Net Debt	$23,628,892	$22,464,766	$348,636	-
Total Debt	$24,767,836	$25,108,964	$350,000	-
Long Term Debt And Capital Lease Obligation	$13,127,122	$12,551,457	$350,000	-
Long Term Debt	$12,600,000	$11,455,085	$350,000	-
Current Debt And Capital Lease Obligation	$11,640,714	$12,557,507	$350,000	-
Current Debt	$11,071,463	$12,038,017	$350,000	-
Other Current Borrowings	$10,887,520	$11,927,816	$250,000	-
Liabilities
Total Liabilities Net Minority Interest	$42,907,250	$50,598,204	$3,238,798	$5,250
Total Non Current Liabilities Net Minority Interest	$13,127,122	$12,551,457	$350,000	$0
Current Liabilities	$29,780,128	$38,046,747	$2,888,798	$5,250
Current Deferred Liabilities	$488,229	$245,765	$0	-
Payables And Accrued Expenses	$13,062,764	$22,131,005	$1,588,798	$5,250
Interest Payable	$833,647	$504,152	$2,333	$0
Payables	$11,915,635	$21,279,024	$1,106,465	$5,250
Accounts Payable	$11,690,635	$6,334,254	$1,038,672	$5,250
Other Payable	-	$10,000,000	-	-
Current Notes Payable	-	-	$100,000	$0
Equity
Common Stock Equity	$-12,447,801	$6,734,446	$-2,900,434	$-5,250
Total Equity Gross Minority Interest	$-12,447,801	$6,734,446	$-2,900,434	$-5,250
Stockholders Equity	$-12,447,801	$6,734,446	$-2,900,434	$-5,250
Retained Earnings	$-111,031,690	$-9,757,160	$-2,900,934	$-5,250
Long Term Equity Investment	-	$17,671	$0	-
Other
Treasury Shares Number	$982,121	-	-	-
Ordinary Shares Number	$2,026,149	$1,038,887	$1,038,887	$1,038,887
Share Issued	$2,026,149	$1,038,887	$1,038,887	$1,038,887
Tangible Book Value	$-38,806,757	$-31,849,509	$-2,900,434	$-5,250
Invested Capital	$11,223,662	$30,227,548	$-2,550,434	$-5,250
Working Capital	$-26,960,912	$-22,878,079	$-2,550,434	$-5,250
Capital Lease Obligations	$1,096,373	$1,615,862	$0	-
Total Capitalization	$152,199	$18,189,531	$-2,550,434	$-5,250
Additional Paid In Capital	$98,573,758	$16,486,501	$-3,972	-
Capital Stock	$10,131	$5,105	$4,472	$0
Common Stock	$10,131	$5,105	$4,472	$0
Long Term Capital Lease Obligation	$527,122	$1,096,372	$0	-
Current Deferred Revenue	$488,229	$245,765	$0	-
Current Capital Lease Obligation	$569,251	$519,490	$0	-
Line Of Credit	$183,943	$110,201	$0	-
Pensionand Other Post Retirement Benefit Plans Current	$4,588,421	$3,112,470	$1,300,000	$0
Current Accrued Expenses	$1,147,129	$851,981	$482,333	$0
Dueto Related Parties Current	$225,000	$4,944,770	$67,793	$0
Goodwill	$14,193,923	$16,219,929	$0	-
Net PPE	$1,196,269	$1,916,308	$0	-
Accumulated Depreciation	$-1,278,460	$-1,119,656	$0	-
Gross PPE	$2,474,729	$3,035,964	$0	-
Leases	$766,467	$766,467	$0	-
Other Properties	$1,556,101	$2,117,336	-	-
Machinery Furniture Equipment	$152,161	$152,161	$0	-
Properties	$0	$0	$0	-
Inventories Adjustments Allowances	$-6,421,816	$-233,601	$0	-
Other Inventories	$5,988,257	$6,717,373	-	-
Finished Goods	$2,072,985	$3,034,836	$0	-
Duefrom Related Parties Current	$0	$1,021,000	$337,000	$0
Investments And Advances	-	$17,671	$0	-

Fetched: 2026-07-06

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-11,736,555	$-1,602,281	$-349,136	$0
Operating Activities
Operating Cash Flow	$-10,855,029	$-1,224,993	$-349,136	$0
Cash Flow From Continuing Operating Activities	$-10,855,029	$-1,224,993	$-349,136	$0
Operating Gains Losses	$2,987,922	-	-	-
Investing Activities
Capital Expenditure	$-881,526	$-377,288	-	-
Investing Cash Flow	$-881,526	$469,072	$0	-
Cash Flow From Continuing Investing Activities	$-881,526	$469,072	$0	-
Capital Expenditure Reported	$-881,526	$-377,288	-	-
Net Other Investing Changes	-	$-85,008	-	-
Financing Activities
Issuance Of Capital Stock	$11,372,840	$10,000	$500	$0
Financing Cash Flow	$10,750,790	$1,782,893	$350,500	$0
Cash Flow From Continuing Financing Activities	$10,750,790	$1,782,893	$350,500	$0
Net Other Financing Charges	$-841,602	$1,152,190	-	-
Net Common Stock Issuance	$11,372,840	$10,000	$500	$0
Common Stock Issuance	$11,372,840	$10,000	$500	$0
Other
Repayment Of Debt	$-24,747,409	$-135,777	$0	-
Issuance Of Debt	$22,668,961	$756,480	$350,000	$0
Interest Paid Supplemental Data	$3,110,776	$332,847	-	-
Income Tax Paid Supplemental Data	$0	$0	-	-
End Cash Position	$42,571	$1,028,336	$1,364	$0
Beginning Cash Position	$1,028,336	$1,364	$0	$0
Changes In Cash	$-985,765	$1,026,972	$1,364	-
Proceeds From Stock Option Exercised	$2,298,000	$0	-	-
Net Issuance Payments Of Debt	$-2,078,448	$620,703	$350,000	$0
Net Short Term Debt Issuance	$-4,024,478	$620,703	$0	$0
Short Term Debt Payments	$-24,094,478	$-135,777	$0	-
Short Term Debt Issuance	$20,070,000	$756,480	$0	$0
Net Long Term Debt Issuance	$1,946,030	$0	$350,000	-
Long Term Debt Payments	$-652,931	$0	-	-
Long Term Debt Issuance	$2,598,961	$0	$350,000	-
Net Business Purchase And Sale	$0	$931,368	$0	-
Sale Of Business	$0	$931,368	$0	-
Change In Working Capital	$8,483,520	$3,342,085	$2,546,548	$5,250
Change In Other Working Capital	$321,090	$3,326,274	$-269,207	-
Change In Other Current Liabilities	$41,746	$22,091	$0	-
Change In Other Current Assets	$0	$-587,539	$0	-
Change In Payables And Accrued Expense	$5,429,464	$682,261	$2,815,755	$5,250
Change In Accrued Expense	$3,233,642	$1,564,576	$1,782,333	$0
Change In Payable	$2,195,822	$-882,315	$1,033,422	$5,250
Change In Account Payable	$2,195,822	$-882,315	$1,033,422	$5,250
Change In Prepaid Assets	$524	$11,435	$0	-
Change In Inventory	$1,890,925	$-72,356	$0	-
Change In Receivables	$799,771	$-40,081	$0	-
Changes In Account Receivables	$799,771	$-40,081	$0	-
Other Non Cash Items	$33,411	-	-	-
Stock Based Compensation	$54,794,525	$1,081,106	$0	-
Provisionand Write Offof Assets	$5,988,257	$0	-	-
Asset Impairment Charge	$14,920,802	$93,378	$0	-
Depreciation Amortization Depletion	$3,211,064	$1,114,664	$0	-
Depreciation And Amortization	$3,211,064	$1,114,664	$0	-
Amortization Cash Flow	$3,052,260	$1,047,048	$0	-
Amortization Of Intangibles	$3,052,260	$1,047,048	$0	-
Depreciation	$158,804	$67,616	$0	-
Net Income From Continuing Operations	$-101,274,530	$-6,856,226	$-2,895,684	$-5,250
Net Intangibles Purchase And Sale	-	$-377,288	$0	-
Purchase Of Intangibles	-	$-377,288	$0	-

Fetched: 2026-07-06